Skip to content
The Min Lu Research Group
Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
State Key Laboratory of Omics and Disease (formerly State Key Laboratory of Medical Genomics)
English
English
中文 (中国)
English
English
中文 (中国)
The Min Lu Research Group
Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
State Key Laboratory of Omics and Disease (formerly State Key Laboratory of Medical Genomics)
English
English
中文 (中国)
Home
Research
Achievements
Group News
Scholarly Developments
Life Moments
Research Group Members
Database(rescue p53)
癌症与p53科普-en
Contact Us
Home
Research
Achievements
Group News
Scholarly Developments
Life Moments
Research Group Members
Database(rescue p53)
癌症与p53科普-en
Contact Us
Loss of anti-tumor function after p53 mutation is one of the main factors leading to cancer occurrence and death
mougen
May 30, 2022
5:24 pm
Compared to patients without p53 mutations,
patients with p53 mutations often have a lower probability of surviving for more than 5 years
Prev
上一个
Although these over 1000 p53 mutations all cause p53 to lose its anti-tumor function, there are multiple pathways through which they cause p53 to lose its function. Therefore, different p53 mutants cannot be confused
下一个
The 25 most common p53 mutants
Next